EP 4313299 A1 20240207 - RECOMBINANT TYPE II COLLAGEN FOR THERAPEUTIC USE
Title (en)
RECOMBINANT TYPE II COLLAGEN FOR THERAPEUTIC USE
Title (de)
REKOMBINANTES TYP II-KOLLAGEN ZUR THERAPEUTISCHEN VERWENDUNG
Title (fr)
COLLAGÈNE DE TYPE II RECOMBINANT À USAGE THÉRAPEUTIQUE
Publication
Application
Priority
- DE 102021202830 A 20210323
- EP 2022057624 W 20220323
Abstract (en)
[origin: WO2022200422A1] The invention relates to a recombinant, particularly non-denatured type II collagen for use in a therapeutic method for oral treatment of cartilage diseases in a human or animal patient.
IPC 8 full level
A61P 19/02 (2006.01); A61K 38/39 (2006.01)
CPC (source: EP KR US)
A61K 9/0053 (2013.01 - US); A61K 38/39 (2013.01 - EP KR US); A61P 19/02 (2018.01 - EP KR US); C07K 14/78 (2013.01 - KR US); C12N 15/815 (2013.01 - US)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
DE 102021202830 A1 20220929; AU 2022241942 A1 20231012; AU 2022241942 A9 20231026; BR 112023019488 A2 20231031; CA 3212264 A1 20220929; CN 117120466 A 20231124; EP 4313299 A1 20240207; JP 2024511604 A 20240314; KR 20230159865 A 20231122; MX 2023011172 A 20230929; US 2024182546 A1 20240606; WO 2022200422 A1 20220929
DOCDB simple family (application)
DE 102021202830 A 20210323; AU 2022241942 A 20220323; BR 112023019488 A 20220323; CA 3212264 A 20220323; CN 202280024384 A 20220323; EP 2022057624 W 20220323; EP 22719203 A 20220323; JP 2023558139 A 20220323; KR 20237035988 A 20220323; MX 2023011172 A 20220323; US 202218283653 A 20220323